|
Volumn 11, Issue 11, 1990, Pages 457-461
|
Development of angiogenesis inhibitors for clinical applications
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
2,2' BIPYRIDINE;
ALPHA INTERFERON;
ANGIOGENESIS INHIBITOR;
AZETIDINE 2 CARBOXYLIC ACID;
BISANTRENE;
CYCLODEXTRIN DERIVATIVE;
EPIHYDROCORTISONE;
GROWTH FACTOR;
HEPARIN;
HYDROXYPROGESTERONE;
METHOTREXATE;
MITOXANTRONE;
PENICILLAMINE;
PROTAMINE;
RETINOID DERIVATIVE;
TRANSHYDROXYPROLINE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANGIOGENESIS;
ARTHRITIS;
ATHEROSCLEROSIS;
CANCER INHIBITION;
CELL MIGRATION;
HUMAN;
KAPOSI SARCOMA;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
TUMOR VASCULARIZATION;
ANIMAL;
CELL MOVEMENT;
FIBROBLAST GROWTH FACTOR 2;
HUMAN;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
SARCOMA, KAPOSI;
|
EID: 0025000576
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/0165-6147(90)90127-T Document Type: Review |
Times cited : (52)
|
References (48)
|